$0.20 Earnings Per Share Expected for Alcentra Capital Corp (NASDAQ:ABDC) This Quarter
Wall Street brokerages expect that Alcentra Capital Corp (NASDAQ:ABDC) will announce $0.20 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Three analysts have issued estimates for Alcentra Capital’s earnings. The lowest EPS estimate is $0.19 and the highest is $0.21. Alcentra Capital posted earnings per share of $0.25 during the same quarter last year, which suggests a negative year-over-year growth rate of 20%. The firm is expected to issue its next quarterly earnings results on Monday, August 5th.
On average, analysts expect that Alcentra Capital will report full year earnings of $0.81 per share for the current financial year, with EPS estimates ranging from $0.79 to $0.83. For the next financial year, analysts forecast that the firm will post earnings of $0.80 per share. Zacks’ earnings per share averages are an average based on a survey of sell-side analysts that cover Alcentra Capital.
Alcentra Capital (NASDAQ:ABDC) last announced its earnings results on Monday, May 6th. The asset manager reported $0.22 EPS for the quarter, meeting the consensus estimate of $0.22. Alcentra Capital had a return on equity of 8.84% and a net margin of 14.50%. The company had revenue of $6.43 million for the quarter, compared to analyst estimates of $6.24 million.
Several institutional investors have recently made changes to their positions in ABDC. Mercer Global Advisors Inc. ADV bought a new stake in shares of Alcentra Capital during the 1st quarter valued at about $85,000. Millennium Management LLC bought a new stake in shares of Alcentra Capital during the 4th quarter valued at about $107,000. Squarepoint Ops LLC bought a new stake in shares of Alcentra Capital during the 4th quarter valued at about $165,000. Oppenheimer & Co. Inc. boosted its position in shares of Alcentra Capital by 226.1% during the 1st quarter. Oppenheimer & Co. Inc. now owns 33,257 shares of the asset manager’s stock valued at $249,000 after purchasing an additional 23,059 shares in the last quarter. Finally, Two Sigma Investments LP bought a new stake in shares of Alcentra Capital during the 4th quarter valued at about $265,000. Institutional investors own 35.65% of the company’s stock.
Shares of Alcentra Capital stock traded down $0.01 on Wednesday, hitting $8.28. 20,900 shares of the company’s stock traded hands, compared to its average volume of 36,223. Alcentra Capital has a one year low of $5.58 and a one year high of $8.74. The firm’s fifty day moving average price is $8.34. The company has a market cap of $106.66 million, a P/E ratio of 8.20 and a beta of 0.62.
The firm also recently announced a None dividend, which was paid on Wednesday, July 3rd. Investors of record on Friday, June 28th were given a dividend of $0.33 per share. The ex-dividend date of this dividend was Thursday, June 27th. This represents a dividend yield of 8.55%. Alcentra Capital’s payout ratio is 71.29%.
Alcentra Capital Company Profile
Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.
Recommended Story: What is Put Option Volume?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.